Moma Therapeutics

Acquisition, funding and merger involving Moma Therapeutics.

• Moma Therapeutics has just announced a $150 Million fundraising (posted on May 12 2022).

View the org chart displaying its 17 main executives

Most searched biographies at Moma Therapeutics

• Asit Parikh, President and Chief Executive Officer
• Walt Kowtoniuk, Director
• Amit Sinha, Director

Popular executive movements at Moma Therapeutics

• Jullian Jones has joined the company as Chief Business Officer  (posted on March 13 2024).

Create your alert
to follow the executive moves at Moma Therapeutics.

Moma Therapeutics has 2,273 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).
• Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).
• Nuvation Bio has announced the acquisition of AnHeart  (posted on April 12 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Moma Therapeutics

• News Feed - MOMA Therapeutics

Social media about Moma Therapeutics

• Moma Therapeutics on Wikipedia, Google News & Yahoo Finance
• Moma Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Asit Parikh

Call Moma Therapeutics at +1 617...

View the org chart

Register to receive your alert

Report an error